ONCAlert | 2017 San Antonio Breast Cancer Symposium

The Convergence of Targeted Therapies and Immuno-Oncology in Sarcoma

George D. Demetri, MD
Published Online:8:40 AM, Tue August 9, 2016

George D. Demetri, MD, senior vice president for Experimental Therapeutics at the Dana-Farber Cancer Institute, professor of Medicine at Harvard Medical School, and co-director of the Ludwig Center at Harvard, discusses the relevance of sarcoma in the converging worlds of targeted therapies and immuno-oncology.
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.